Lineage Cell Therapeutics (LCTX) Revenue (2010 - 2026)
Lineage Cell Therapeutics (LCTX) reported Revenue of $1.07 million for Q2 2026, down 61.3% from $2.77 million a year earlier and down 38.0% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Revenue (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Lineage Cell Therapeutics' Revenue came in at $13.08 million, up 19.9% year-over-year; for FY2025, it was $14.56 million, up 53.2% from FY2024.
- Revenue has a five-year compound annual growth rate of 51.5% (FY2020 to FY2025).
- By year, Revenue came in at $9.5 million in FY2024 (+6.2%), $8.95 million in FY2023 (-39.2%), $14.7 million in FY2022 (+238.7%) and $4.34 million in FY2021 (+137.7%).
- The Q2 2026 figure ranks as the lowest quarterly Revenue since Q2 2021.
- Year over year, Revenue gained in six of the last eight quarters, with growth averaging 52.8%.
- The high point for year-over-year Revenue in five years was Q2 2022 (growth of 789.3%); the low point was Q2 2026 (a decline of 61.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.73 million (Q1 2026), $6.61 million (Q4 2025) and $3.68 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 25.31 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 16.99 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 16.61 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 14.41 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 15.38 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 10.05 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 7.80 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 15.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 3.33 Bn |
| 10 | Lineage Cell Therapeutics | 245.32 Mn | 43.73 Mn | - | 1.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.73 Mn |
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 3.68 Mn |
| Jun 30, 2025 | 2.77 Mn |
| Mar 31, 2025 | 1.50 Mn |
| Dec 31, 2024 | 2.87 Mn |
| Sep 30, 2024 | 3.78 Mn |
| Jun 30, 2024 | 1.41 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 2.09 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 2.39 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 4.55 Mn |
| Mar 31, 2022 | 5.24 Mn |
| Dec 31, 2021 | 1.17 Mn |
| Sep 30, 2021 | 2.27 Mn |
API Access
Lineage Cell Therapeutics Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();